Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2015

Nowak DG, Cho H, Herzka T, Watrud K, DeMarco DV, M Y Wang V, et al. MYC Drives Pten/Trp53-Deficient Proliferation and Metastasis due to IL6 Secretion and AKT Suppression via PHLPP2. Cancer Discov. 2015;5(6):636-51.

Rodrigues LU, Rider L, Nieto C, Romero L, Karimpour-Fard A, Loda M, et al. Coordinate loss of MAP3K7 and CHD1 promotes aggressive prostate cancer. Cancer Res. 2015;75(6):1021-34.

2014

Gao D, Vela I, Sboner A, Iaquinta PJ, Karthaus WR, Gopalan A, et al. Organoid cultures derived from patients with advanced prostate cancer. Cell. 2014;159(1):176-187.

Goyal A, Yang B. Cytologic features of stratified mucin producing intraepithelial lesion of the cervix--a case report. Diagn Cytopathol. 2014;42(9):792-7.

Fan CQ, Crawford JM. Sinusoidal obstruction syndrome (hepatic veno-occlusive disease). J Clin Exp Hepatol. 2014;4(4):332-46.

Fatima N, Cohen C, Siddiqui MT. Arginase-1: a highly specific marker separating pancreatic adenocarcinoma from hepatocellular carcinoma. Acta Cytol. 2014;58(1):83-8.

Shipitsin M, Small C, Choudhury S, Giladi E, Friedlander S, Nardone J, et al. Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error. Br J Cancer. 2014;111(6):1201-12.

Boya P, Diaz-Meco MT, Rubinsztein D, Sass M. Autophagy researchers. Autophagy. 2014;10(3):393-6.

Jawed SI, Busam K, Wang X, Horwitz S, Querfeld C. Cutaneous hemophagocytosis after alemtuzumab injection in a patient with Sézary syndrome. JAMA Dermatol. 2014;150(9):1021-3.

Hu Z, Chen K, Li W, Tyler JK. A matter of access. Nucleosome disassembly from gene promoters is the central goal of transcriptional activators. Transcription. 2014;5(2):e29355.